Recent trends in acute coronary heart disease: Mortality, morbidity, medical care, and risk factors

New England Journal of Medicine

Volumn 334, Issue 14, 1996, Pages 884-890

  Mcgovern, Paul G ^a   Pankow, James S ^a   Shahar, Eyal ^a   Doliszny, Katherine M ^a   Folsom, Aaron R ^a   Blackburn, Henry ^a   Luepker, Russell V ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOLYTIC AGENT; HEPARIN; WARFARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; CORONARY RISK; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNITED STATES;

ACUTE DISEASE; ADULT; AGED; COHORT STUDIES; CORONARY DISEASE; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MINNESOTA; MORTALITY; MYOCARDIAL INFARCTION; RISK FACTORS; SURVIVAL RATE; THROMBOLYTIC THERAPY;

EID: 0029993565     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199604043341403     Document Type: Article

References (34)

1. Thom TJ, Maurer J. Time trends for coronary heart disease mortality and morbidity. In: Higgins MW, Luepker RV, eds. Trends in coronary heart disease mortality: the influence of medical care. New York: Oxford University Press, 1988:7-15.
2. Gillum RF. Trends in acute myocardial infarction and coronary heart disease death in the United States J Am Coll Cardiol 1994;23:1273-7
3. National Center for Health Statistics. Advance report of final mortality statistics, 1990. Mon Vital Stat Rep 1993;41(7):Suppl.
4. Sytkowski PA, Kannel WB, D'Agostino RB Changes in risk factors and the decline in mortality from cardiovascular disease: the Framingham Heart Study N Engl J Med 1990,322:1635-41.
5. Weisfeldt ML. Acute myocardial infarction, in-hospital management, introduction In: Higgins MW, Luepker RV, eds. Trends in coronary heart disease mortality the influence of medical care. New York: Oxford University Press, 1988:171-3.
6. Rapaport E. The influence of medical care on chronic coronary disease: introduction In: Higgins MW, Luepker RV, eds. Trends in coronary heart disease mortality: the influence of medical care. New York: Oxford University Press, 1988 221-6.
7. Burnand B, Feinstein AR. The role of diagnostic inconsistency in changing rates of occurrence for coronary heart disease J Clin Epidemiol 1992;45: 929-40
8. Pankow JS, McGovern PG, Sprafka JM, Jacobs DR Jr, Blackburn H Trends in coded causes of death following definite myocardial infarction and the role of competing risks: the Minnesota Heart Survey (MHS) J Clin Epidemiol 1994,47:1051-60.
9. Assaf AR, Lapane KL, McKenney JL, Carleton RA. Possible influence of the prospective payment system on the assignment of discharge diagnoses for coronary heart disease N Engl J Med 1993;329.931-5.
10. Goldberg RJ, Gorak EJ, Yarzebski J, et al A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease. Circulation 1993;87:1947-53.
11. Burke GL, Sprafka JM, Folsom AR, Luepker RV, Norsted SW, Blackburn H Trends in CHD mortality, morbidity and risk factor levels from 1960 to 1986. Int J Epidemiol 1989;18:Suppl:S73-S81
12. Gomez-Marin O, Folsom AR, Kottke TE, et al. Improvement in long-term survival among patients hospitalized with acute myocardial infarction, 1970 to 1980: the Minnesota Heart Survey. N Engl J Med 1987;316:1353-9
13. McGovern PG, Folsom AR, Sprafka JM, et al. Trends in survival of hospitalized myocardial infarction patients between 1970 and 1985. Circulation 1992;85:172-9
14. Department of Health and Human Services. The international classification of diseases, 9th rev, clinical modification. ICD-9-CM, Vol. 1 Diseases: tabular list. Washington, D.C . Government Printing Office, 1980. (DHHS publication no. (PHS) 80-1260.)
15. Folsom AR, Gomez-Marin O, Gillum RF, Kottke TE, Lohman W, Jacobs DR Jr. Out-of-hospital coronary death in an urban population - validation of death certificate diagnosis. Am J Epidemiol 1987;125:1012-8.
16. Edlavitch SA, Crow R, Burke GL, Huber J, Prineas R, Blackburn H. The effect of the number of electrocardiograms analyzed on cardiovascular disease surveillance the Minnesota Heart Survey (MHS). J Clin Epidemiol 1990;43:93-9
17. Edlavitch SA, Baxter J. Comparability of mortality follow-up before and after the National Death Index Am J Epidemiol 1988;127:1164-78
18. Sprafka JM, Burke GL, Folsom AR, Luepker RV, Blackburn H. Continued decline in cardiovascular disease risk factors: results of the Minnesota Heart Survey, 1980-1982 and 1985-1987 Am J Epidemiol 1990;132:489-500.
19. Burke GL, Sprafka JM, Folsom AR, Hahn LP, Luepker RV, Blackburn H. Trends in serum cholesterol levels from 1980 to 1987. the Minnesota Heart Survey. N Engl J Med 1991,324:941-6
20. Butts WC, Kueheman J, Widdowson GM Automated method for determining serum thiocyanate to distinguish smokers from nonsmokers. Clin Chem 1974;20:1344-8.
21. Taylor HL, Jacobs DR, Schucker B, Knudsen J, Leon AS, Debacker G A questionnaire for the assessment of leisure time physical activities J Chronic Dis 1978,31:741-55.
22. Frome EL, Checkoway H. Epidemiologic programs for computers and calculators: use of Poisson regression models in estimating incidence rates and ratios. Am J Epidemiol 1985;121:309-23.
23. Tarone RE On summary estimators of relative risk. J Chronic Dis 1981;34: 463-8.
24. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients Lancet 1994;343:311-22. [Erratum, Lancet 1994;343:742]
25. Sempos CT, Cleeman JI, Carroll MD, et al. Prevalence of high blood cholesterol among US adults: an update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel. JAMA 1993;269:3009-14.
26. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNCV) Arch Intern Med 1993,153 154-83.
27. National Center for Health Statistics. Healthy People 2000 review, health, United States, 1992. Hyattsville, Md.: Public Health Service, 1993. (DHHS publication no. (PHS) 93-1232.)
28. National Center for Health Statistics, Graves EJ. National Hospital Discharge Survey: annual summary, 1990. Vital and health statistics. Series 13 No 112. Washington, D C., Government Printing Office, 1992. (DHHS publication no (PHS) 92-1773.)
29. Delborg M, Eriksson P, Riha M, Swedberg K Declining hospital mortality in acute myocardial infarction. Eur Heart J 1994,15:5-9.
30. ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction. ISIS-2. Lancet 1988;2:349-60
31. Smith P, Arnesen H, Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction N Engl J Med 1990;323:147-52
32. Naylor DC, Chen E. Population-wide mortality trends among patients hospitalized for acute myocardial infarction: the Ontario experience, 1981 to 1991. J Am Coll Cardiol 1994;24:1431-8.
33. Pashos CL, Newhouse JP, McNeil BJ Temporal changes in the care and outcomes of elderly patients with acute myocardial infarction: 1987 through 1990 JAMA 1993;270 1832-6.
34. Pashos CL, Normand ST, Garfinkle JB, Newhouse JP, Epstein AM, McNeil BJ Trends in the use of drug therapies in patients with acute myocardial infarction: 1988 to 1992. J Am Coll Cardiol 1994;23:1023-30.